基本信息
文件名称:FLT3-VEGFR2-IN-1-生命科学试剂-MCE.pdf
文件大小:457.67 KB
总页数:1 页
更新时间:2025-03-19
总字数:约2.06千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

FLT3/VEGFR2-IN-1

Cat.No.:HY-168493

分?式:C??H??N?O?

分?量:561.63

作?靶点:FLT3;VEGFR;HDAC;STAT;PERK

作?通路:ProteinTyrosineKinase/RTK;CellCycle/DNADamage;

Epigenetics;JAK/STATSignaling;StemCell/Wnt

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性FLT3/VEGFR2-IN-1(Compound26)是?种FLT3/VEGFR2/HDAC抑制剂,对FLT3、VEGFR2和HDAC1的

IC50分别为14.5、3.9和30.8nM。FLT3/VEGFR2-IN-1可抑制STAT3和ERK1/2的磷酸化和??病细胞的增殖

。FLT3/VEGFR2-IN-1具有抗肿瘤的活性,可?于急性髓系??病的研究。

REFERENCES

[1].TianH,etal.Design,Synthesis,andBiologicalEvaluationofNovelFms-LikeTyrosineKinase3/VEGFR2/HistoneDeacetylaseInhibitors

fortheTreatmentofAcuteMyeloidLeukemia.JMedChem.2025Feb19.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1